Does IMATINIB Cause Product dose omission issue? 203 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 203 reports of Product dose omission issue have been filed in association with IMATINIB (Imatinib). This represents 0.5% of all adverse event reports for IMATINIB.
203
Reports of Product dose omission issue with IMATINIB
0.5%
of all IMATINIB reports
8
Deaths
32
Hospitalizations
How Dangerous Is Product dose omission issue From IMATINIB?
Of the 203 reports, 8 (3.9%) resulted in death, 32 (15.8%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 203 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which IMATINIB Alternatives Have Lower Product dose omission issue Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL